As of 2026-10-17, the Relative Valuation of Algernon Pharmaceuticals Inc (AGN.CN) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.36 CAD, the upside of Algernon Pharmaceuticals Inc based on Relative Valuation is -103.1%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -102.4% - -103.7% | -103.1% |
| Date | P/E |
| 2026-10-01 | -1.64 |
| 2026-09-30 | -1.64 |
| 2026-09-29 | -1.71 |
| 2026-09-28 | -2.08 |
| 2026-09-23 | -1.98 |
| 2026-09-22 | -2.01 |
| 2026-09-17 | -2.08 |
| 2026-09-15 | -2.54 |
| 2026-09-14 | -2.54 |
| 2026-09-11 | -2.54 |
| 2026-09-10 | -2.54 |
| 2026-09-09 | -2.63 |
| 2026-09-08 | -2.77 |
| 2026-09-04 | -2.54 |
| 2026-09-03 | -2.77 |
| 2026-09-01 | -2.77 |
| 2026-08-31 | -2.31 |
| 2026-08-28 | -2.31 |
| 2026-08-27 | -2.31 |
| 2026-08-26 | -2.21 |
| 2026-08-24 | -2.08 |
| 2026-08-21 | -2.17 |
| 2026-08-20 | -2.03 |
| 2026-08-19 | -2.10 |
| 2026-08-17 | -2.01 |
| 2026-08-14 | -2.08 |
| 2026-08-13 | -2.12 |
| 2026-08-12 | -2.17 |
| 2026-08-11 | -2.03 |
| 2026-08-07 | -1.87 |
| 2026-08-06 | -1.78 |
| 2026-08-05 | -1.89 |
| 2026-08-04 | -1.75 |
| 2026-07-31 | -1.62 |
| 2026-07-30 | -1.68 |
| 2026-07-29 | -1.73 |
| 2026-07-28 | -1.75 |
| 2026-07-27 | -1.73 |
| 2026-07-24 | -1.80 |
| 2026-07-23 | -1.82 |
| 2026-07-22 | -1.78 |
| 2026-07-21 | -1.73 |
| 2026-07-20 | -1.73 |
| 2026-07-17 | -1.92 |
| 2026-07-16 | -1.85 |
| 2026-07-15 | -1.78 |
| 2026-07-14 | -1.98 |